Covert administration means giving a medicine in a disguised form without the resident knowing. It is not a convenient response to refusal. A person who has capacity for the particular medicine decision may refuse, even when relatives or staff believe that choice is unwise. Covert use should arise only after decision-specific capacity assessment, practicable support, a multidisciplinary best-interests process, medicine-by-medicine planning and regular review. Families should inspect the reasoning and governance, not attempt to choose a crushing, mixing or dosing method themselves.
Distinguish refusal from lack of capacity
A resident may spit out a tablet because it is painful to swallow, causes side effects, conflicts with beliefs, is offered at the wrong time, or is not understood. Explore those reasons and offer communication support before assuming incapacity. The guide to care and medicine refusal outlines practical, rights-respecting questions.
Capacity is specific to the decision and time. A dementia diagnosis, detention, family concern or apparently unwise decision does not remove it automatically. The assessment should record the information the person needs, how it was explained, whether they can understand, retain, use or weigh it, and communicate a choice. Fluctuating capacity requires timing and repeated support.
Try less restrictive options first
Identify whether the person can take the medicine openly in a different licensed formulation, at another time, with a trusted staff member, or after symptoms such as nausea or pain are addressed. The prescriber and pharmacist should consider whether the medicine remains necessary and whether a clinically appropriate alternative exists. Staff should record each attempt and the resident’s response.
These steps are not permission for relatives to conceal medicines at home or bring altered doses into the service. Changing a formulation can affect absorption, effectiveness and safety. Only the responsible professionals can advise on a particular product and administration plan.
Hold a genuine best-interests meeting
If the person lacks capacity for the medicine decision, the team should consider best interests and the least restrictive option. The meeting should involve care staff, the prescriber, a pharmacist, and someone able to represent the resident’s wishes and values, such as family, an attorney or advocate as appropriate. The decision cannot be delegated to one hurried staff member.
Discuss benefits, burdens, alternatives, known past wishes, beliefs, side effects and the consequences of not giving each medicine. An attorney with relevant health-and-welfare authority may have a formal role. A relative without such authority contributes valuable evidence but does not simply consent on the resident’s behalf.
Make the decision medicine-specific
A blanket instruction to hide “all medication” is inadequate. The plan should identify each medicine, why it is essential, whether covert use is in the person’s best interests, and the professional advice on safe administration. Adding a medicine or changing its dose requires the need and decision to be reconsidered.
The pharmacist must advise whether the proposed formulation and method remain safe and effective, and the prescriber must know when administration is altered. Families should never crush a modified-release tablet, open a capsule, or mix a medicine based on a general article. Those are product-specific clinical decisions with potentially serious consequences.
Demand a usable management and recording plan
The care plan should state the capacity finding, best-interests participants and outcome, medicines covered, authorised method, what happens if food or drink is refused, monitoring, adverse-effect response and review date. The medicines administration record should show what was actually given covertly and when. Staff need training and access to the current version.
Ask how the home handles agency staff, hospital transfers, family visits and temporary leave. A covert plan should not travel as an unlabeled instruction detached from its legal reasoning. Use this guide to arranging a structured medication review to question necessity, duplication and side effects separately.
Review need and capacity, not only the prescription
Covert administration should last no longer than needed. Set review frequency according to the person’s circumstances, including fluctuating capacity, changes in behaviour, new swallowing difficulty, side effects and altered treatment goals. Each formal review should state whether covert use remains necessary for each medicine and whether a less restrictive route is now possible.
An annual medicines review alone may be too remote for a rapidly changing situation. Ask who can pause the plan and seek urgent advice. Sudden refusal, drowsiness, choking, delirium or other deterioration requires clinical assessment rather than automatic concealment.
Use a review trigger sheet rather than only a calendar date. Triggers may include a new medicine, dose change, repeated partial doses, refusal of the food vehicle, altered swallowing, a hospital return, recovery from delirium or a new attorney decision. Each trigger should lead staff back to capacity, best interests and pharmaceutical advice instead of treating the old instruction as permanent.
Escalate undocumented or unsafe practice
Start with the manager, prescriber and supplying pharmacist. Ask for the capacity assessment, best-interests record, management plan and administration entries that the resident or authorised representative is entitled to see. If staff are hiding medicine from a capacitous resident, acting without a plan, or continuing despite harm, raise an urgent safeguarding and clinical concern.
The UK care-home directory and planning hub can assist if a different placement is considered, but another home must independently assess needs and current availability. A medication concern does not itself authorise an emergency transfer.
Can family ask staff to hide a medicine?
Family can raise concerns and provide evidence about the resident’s wishes, but cannot bypass capacity and best-interests safeguards. Covert administration requires professional, multidisciplinary and medicine-specific decision-making. A relevant attorney may have formal authority, yet the Mental Capacity Act principles, least-restrictive approach, pharmacist input and documentation still apply.
Is crushing a tablet into food always acceptable?
No. Altering a tablet or capsule can make treatment ineffective, unsafe or unlicensed, and some formulations must not be crushed. The pharmacist and prescriber must advise on the exact medicine and proposed method after the legal decision to use covert administration is made. This article intentionally provides no product technique or dosing instruction.
Who authorises covert use and admission?
The care and health professionals complete and document the capacity, best-interests and medicine-specific plan with the resident’s representative or advocate involved as appropriate; the prescriber and pharmacist determine clinical suitability; and regulators or safeguarding authorities address unsafe practice. The care home separately decides whether it can safely meet the resident’s needs and has a place. No family request or online guidance authorises covert administration.
